The paradox of Akt-mTOR interactions

Frontiers in Oncology

Volumn 3 JUN, Issue , 2013, Pages

  Vadlakonda, Lakshmipathi ^a   Dash, Abhinandita ^a   Pasupuleti, Mukesh ^b   Kumar, Kotha Anil ^c   Reddanna, Pallu ^c  

^a KAKATIYA UNIVERSITY   (India)

^b SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

^c UNIVERSITY OF HYDERABAD   (India)

Author keywords

Akt; FoxO; Glucose transport; Insulin IGF signaling; Rictor

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; GLUCOSE TRANSPORTER 4; HEAT SHOCK PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INTEGRIN LINKED KINASE; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3, 4 BISPHOSPHATE; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; SERINE; SIRTUIN 3; SOMATOMEDIN; THREONINE; TRANSCRIPTION FACTOR FOXO; TUBERIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; CELL CYCLE PROGRESSION; CELL ENERGY; CELL FUNCTION; CELL METABOLISM; CELL STRESS; CELL SURVIVAL; DIET RESTRICTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME STABILITY; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; MOLECULAR INTERACTION; NEOPLASM; NONHUMAN; NUTRIENT; PROTEIN PROTEIN INTERACTION; RNA TRANSLATION; SIGNAL TRANSDUCTION;

EID: 84886235912     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00165     Document Type: Article

References (93)

1. Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P., et al. (1996). Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541-6551.
2. Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R., Reese, C. B., et al. (1997). Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol. 7, 261-269. doi:10.1016/S0960-9822(06)00122-9.
3. Ananthanarayanan, B., Fosbrink, M., Rahdar, M., and Zhang, J. (2007). Live-cell molecular analysis of Akt activation reveals roles for activation loop phosphorylation. J. Biol. Chem. 282, 36634-36641. doi:10.1074/jbc.M706227200.
4. Atkinson, D. E. (1968). The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry 7, 4030-4034. doi:10.1021/bi00851a033.
5. Bayascas, J. R., and Alessi, D. R. (2005). Regulation of Akt/PKB Ser473 phosphorylation. Mol. Cell 18, 143-145. doi:10.1016/j.molcel.2005.03.020.
6. Bellacosa, A., Testa, J. R., Staal, S. P., and Tsichlis, P. N. (1991). A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254, 274-277. doi:10.1126/science.1833819.
7. Boosani, C. S., and Agrawal, D. K. (2013). PTEN modulators: a patent review. Expert Opin. Ther. Pat. 23, 569-580. doi:10.1517/13543776.2013.768985.
8. Bozulic, L., Surucu, B., Hynx, D., and Hemmings, B. A. (2008). PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Mol. Cell 30, 203-213. doi:10.1016/j.molcel.2008.02.024.
9. Breuleux, M., Klopfenstein, M., Stephan, C., Doughty, C. A., Barys, L., Maira, S. M., et al. (2009). Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition. Mol. Cancer Ther. 8, 742-753. doi:10.1158/1535-7163.MCT-08-0668.
10. Brugge, J., Hung, M. C., and Mills, G. B. (2007). A new mutational AKTivation in the PI3K pathway. Cancer Cell 12, 104-107. doi:10.1016/j.ccr.2007.07.014.
11. Calleja, V., Laguerre, M., and Larijani, B. (2009a). 3-D structure and dynamics of protein kinase B-new mechanism for the allosteric regulation of an AGC kinase. J. Chem. Biol. 2, 11-25. doi:10.1007/s12154-009-0016-8.
12. Calleja, V., Laguerre, M., Parker, P. J., and Larijani, B. (2009b). Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition. PLoS Biol. 7:e17. doi:10.1371/journal.pbio.1000017.
13. Chan, T. O., and Tsichlis, P. N. (2001). PDK2: a complex tail in one Akt. Sci. STKE 2001, e1. doi:10.1126/stke.2001.66.pe1.
14. Chan, T. O., Zhang, J., Rodeck, U., Pascal, J. M., Armen, R. S., Spring, M., et al. (2011). Resistance of Akt kinases to dephosphorylation through ATP-dependent conformational plasticity. Proc. Natl. Acad. Sci. U.S.A. 108, E1120-E1127. doi:10.1073/pnas.1109879108.
15. Chandrasekher, G., and Sailaja, D. (2004). Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival. Invest. Ophthalmol. Vis. Sci. 45, 3577-3588. doi:10.1167/iovs.04-0279.
16. Chen, C. C., Jeon, S. M., Bhaskar, P. T., Nogueira, V., Sundararajan, D., Tonic, I., et al. (2010). FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and rictor. Dev. Cell 18, 592-604. doi:10.1016/j.devcel.2010.03.008.
17. Coffer, P. J., and Woodgett, J. R. (1991). Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. Eur. J. Biochem. 201, 475-481. doi:10.1111/j.1432-1033.1991.tb16305.x.
18. Dong, L. Q., and Liu, F. (2005). PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle. Am. J. Physiol. Endocrinol. Metab. 289, E187-E196. doi:10.1152/ajpendo.00011.2005.
19. Downward, J. (1995). Signal transduction. A target for PI(3) kinase. Nature 376, 553-554.
20. Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., et al. (2011). Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331, 456-461. doi:10.1126/science.1196371.
21. Eke, I., Koch, U., Hehlgans, S., Sandfort, V., Stanchi, F., Zips, D., et al. (2010). PINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1alpha. J. Clin. Invest. 120, 2516-2527. doi:10.1172/JCI41078.
22. Feng, J., Park, J., Cron, P., Hess, D., and Hemmings, B. A. (2004). Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J. Biol. Chem. 279, 41189-41196. doi:10.1074/jbc.M406731200.
23. Franke, T. F., Yang, S. I., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., et al. (1995). The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81, 727-736. doi:10.1016/0092-8674(95)90534-0.
24. Frias, M. A., Thoreen, C. C., Jaffe, J. D., Schroder, W., Sculley, T., Carr, S. A., et al. (2006). mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr. Biol. 16, 1865-1870. doi:10.1016/j.cub.2006.08.001.
25. Fruman, D. A., Meyers, R. E., and Cantley, L. C. (1998). Phosphoinositide kinases. Annu. Rev. Biochem. 67, 481-507. doi:10.1146/annurev.biochem.67.1.481.
26. Fukuda, M. (2011). TBC proteins: GAPs for mammalian small GTPase Rab? Biosci. Rep. 31, 159-168. doi:10.1042/BSR20100112.
27. Gallay, N., Dos Santos, C., Cuzin, L., Bousquet, M., Simmonet Gouy, V., Chaussade, C., et al. (2009). The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemia. Leukemia 23, 1029-1038. doi:10.1038/leu.2008.395.
28. Gao, T., Furnari, F., and Newton, A. C. (2005). PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell 18, 13-24. doi:10.1016/j.molcel.2005.03.008.
29. Goncharova, E. A., Goncharov, D. A., Li, H., Pimtong, W., Lu, S., Khavin, I., et al. (2011). mTORC2 is required for proliferation and survival of TSC2-null cells. Mol. Cell. Biol. 31, 2484-2498. doi:10.1128/MCB.01061-10.
30. Gu, Y., Lindner, J., Kumar, A., Yuan, W., and Magnuson, M. A. (2011). Rictor/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size. Diabetes 60, 827-837. doi:10.2337/db10-1194.
31. Guan, H., Song, L., Cai, J., Huang, Y., Wu, J., Yuan, J., et al. (2011). Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells. PLoS ONE 6:e19946. doi:10.1371/journal.pone.0019946.
32. Guertin, D. A., Stevens, D. M., Thoreen, C. C., Burds, A. A., Kalaany, N. Y., Moffat, J., et al. (2006). Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev. Cell 11, 859-871. doi:10.1016/j.devcel.2006.10.007.
33. Guo, S., Dunn, S. L., and White, M. F. (2006). The reciprocal stability of FOXO1 and IRS2 creates a regulatory circuit that controls insulin signaling. Mol. Endocrinol. 20, 3389-3399. doi:10.1210/me.2006-0092.
34. Hardie, D. G. (2011). AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev. 25, 1895-1908. doi:10.1101/gad.17420111.
35. Hardie, D. G., and Hawley, S. A. (2001). AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 23, 1112-1119. doi:10.1002/bies.10009.
36. Hill, M. M., Andjelkovic, M., Brazil, D. P., Ferrari, S., Fabbro, D., and Hemmings, B. A. (2001). Insulin-stimulated protein kinase B phosphorylation on Ser-473 is independent of its activity and occurs through a staurosporine-insensitive kinase. J. Biol. Chem. 276, 25643-25646. doi:10.1074/jbc.C100174200.
37. Hollander, M. C., Blumenthal, G. M., and Dennis, P. A. (2011). PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat. Rev. Cancer 11, 289-301. doi:10.1038/nrc3037.
38. Humphrey, S. J., and James, D. E. (2012). Uncaging akt. Sci. Signal. 5:e20. doi:10.1126/scisignal.2003085.
39. Ikenoue, T., Inoki, K., Yang, Q., Zhou, X., and Guan, K. L. (2008). Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. 27, 1919-1931. doi:10.1038/emboj.2008.119.
40. Jones, P. F., Jakubowicz, T., Pitossi, F. J., Maurer, F., and Hemmings, B. A. (1991). Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc. Natl. Acad. Sci. U.S.A. 88, 4171-4175. doi:10.1073/pnas.88.10.4171.
41. Kim, J., Kundu, M., Viollet, B., and Guan, K. L. (2011). AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132-141. doi:10.1038/ncb2152.
42. King, T. D., Song, L., and Jope, R. S. (2006). AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3. Biochem. Pharmacol. 71, 1637-1647. doi:10.1016/j.bcp.2006.03.005.
43. Kohn, A. D., Kovacina, K. S., and Roth, R. A. (1995). Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J. 14, 4288-4295.
44. Konishi, H., Karakas, B., Abukhdeir, A. M., Lauring, J., Gustin, J. P., Garay, J. P., et al. (2007). Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation. Cancer Res. 67, 8460-8467. doi:10.1158/0008-5472.CAN-07-0108.
45. Kumar, A., Lawrence, J. C. Jr., Jung, D. Y., Ko, H. J., Keller, S. R., Kim, J. K., et al. (2010). Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes 59, 1397-1406. doi:10.2337/db09-1061.
46. Kunkel, M. T., Ni, Q., Tsien, R. Y., Zhang, J., and Newton, A. C. (2005). Spatio-temporal dynamics of protein kinase B/Akt signaling revealed by a genetically encoded fluorescent reporter. J. Biol. Chem. 280, 5581-5587. doi:10.1074/jbc.M411534200.
47. Kwiatkowski, D. J., and Manning, B. D. (2005). Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum. Mol. Genet. 14, 251-258. doi:10.1093/hmg/ddi260.
48. Laplante, M., and Sabatini, D. M. (2012). mTOR signaling in growth control and disease. Cell 149, 274-293. doi:10.1016/j.cell.2012.03.017.
49. Lee, S. E., Sun, S. C., Choi, H. Y., Uhm, S. J., and Kim, N. H. (2012). mTOR is required for asymmetric division through small GTPases in mouse oocytes. Mol. Reprod. Dev. 79, 356-366. doi:10.1002/mrd.22035.
50. Liang, J., and Mills, G. B. (2013). AMPK: a contextual oncogene or tumor suppressor? Cancer Res. 73, 2929-2935. doi:10.1158/0008-5472.CAN-12-3876.
51. Lin, K., Lin, J., Wu, W. I., Ballard, J., Lee, B. B., Gloor, S. L., et al. (2012). An ATP-site on-off switch that restricts phosphatase accessibility of Akt. Sci. Signal. 5, ra37. doi:10.1126/scisignal.2002618.
52. Liu, H., Fergusson, M. M., Wu, J. J., Rovira, I. I., Liu, J., Gavrilova, O., et al. (2011). Wnt signaling regulates hepatic metabolism. Sci. Signal. 4, ra6. doi:10.1126/scisignal.2001249.
53. Macreadie, I. G., Horaitis, O., Verkuylen, A. J., and Savin, K. W. (1991). Improved shuttle vectors for cloning and high-level Cu(2+)-mediated expression of foreign genes in yeast. Gene 104, 107-111. doi:10.1016/0378-1119(91)90474-P.
54. Maehama, T., and Dixon, J. E. (1998). The tumor suppressor. J. Biol. Chem. 273, 13375-13378. doi:10.1074/jbc.273.22.13375.
55. Mahajan, K., and Mahajan, N. P. (2012). PI3K-independent AKT activation in cancers: a treasure trove for novel therapeutics. J. Cell. Physiol. 227, 3178-3184. doi:10.1002/jcp.24065.
56. McDonald, P. C., Oloumi, A., Mills, J., Dobreva, I., Maidan, M., Gray, V., et al. (2008). Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res. 68, 1618-1624. doi:10.1158/0008-5472.CAN-07-5869.
57. Mercken, E. M., Crosby, S. D., Lamming, D. W., Jebailey, L., Krzysik-Walker, S., Villareal, D., et al. (2013). Calorie restriction in humans inhibits the PI3K/AKT pathway and induces a younger transcription profile. Aging Cell. doi:10.1111/acel.12088. [Epub ahead of print].
58. Mester, J., and Eng, C. (2013). When overgrowth bumps into cancer: the PTEN-opathies. Am. J. Med. Genet. C Semin. Med. Genet. 163, 114-121. doi:10.1002/ajmg.c.31364.
59. Moore, S. F., Hunter, R. W., and Hers, I. (2011). mTORC2-mediated Akt Ser473 phosphorylation is not required for Akt1 activity in human platelets. J. Biol. Chem. 36, 374-387. doi:10.1074/jbc.M110.202341.
60. Nicholson, K. M., and Anderson, N. G. (2002). The protein kinase B/Akt signalling pathway in human malignancy. Cell. Signal. 14, 381-395. doi:10.1016/S0898-6568(01)00271-6.
61. Nyakern, M., Tazzari, P. L., Finelli, C., Bosi, C., Follo, M. Y., Grafone, T., et al. (2006). Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients. Leukemia 20, 230-238. doi:10.1038/sj.leu.2404057.
62. Oakhill, J. S., Scott, J. W., and Kemp, B. E. (2012). AMPK functions as an adenylate charge-regulated protein kinase. Trends Endocrinol. Metab. 23, 125-132. doi:10.1016/j.tem.2011.12.006.
63. Oakhill, J. S., Steel, R., Chen, Z. P., Scott, J. W., Ling, N., Tam, S., et al. (2011). AMPK is a direct adenylate charge-regulated protein kinase. Science 332, 1433-1435. doi:10.1126/science.1200094.
64. O'Toole, A., Moule, S. K., Lockyer, P. J., and Halestrap, A. P. (2001). Tumour necrosis factor-alpha activation of protein kinase B in WEHI-164 cells is accompanied by increased phosphorylation of Ser473, but not Thr308. Biochem. J. 359, 119-127. doi:10.1042/0264-6021:3590119.
65. Peserico, A., Chiacchiera, F., Grossi, V., Matrone, A., Latorre, D., Simonatto, M., et al. (2013). A novel AMPK-dependent FoxO3A-SIRT3 intramitochondrial complex sensing glucose levels. Cell. Mol. Life Sci. 70, 2015-2029. doi:10.1007/s00018-012-1244-6.
66. Ramaiah, A., Hathaway, J. A., and Atkinson, D. E. (1964). Adenylate as a metabolic regulator. effect on yeast phosphofructokinase kinetics. J. Biol. Chem. 239, 3619-3622.
67. Resjo, S., Goransson, O., Harndahl, L., Zolnierowicz, S., Manganiello, V., and Degerman, E. (2002). Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes. Cell. Signal. 14, 231-238. doi:10.1016/S0898-6568(01)00238-8.
68. Rodrik-Outmezguine, V. S., Chandarlapaty, S., Pagano, N. C., Poulikakos, P. I., Scaltriti, M., Moskatel, E., et al. (2012). mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling. Cancer Discov. 1, 248-259. doi:10.1158/2159-8290.CD-11-0085.
69. Salminen, A., and Kaarniranta, K. (2013). Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-kappaB signaling. Cell. Signal. 22, 573-577. doi:10.1016/j.cellsig.2009.10.006.
70. Sarbassov, D. D., Guertin, D. A., Ali, S. M., and Sabatini, D. M. (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101. doi:10.1126/science.1106148.
71. Scheid, M. P., Marignani, P. A., and Woodgett, J. R. (2002). Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B. Mol. Cell. Biol. 22, 6247-6260. doi:10.1128/MCB.22.17.6247-6260.2002.
72. Schwenk, R. W., Dirkx, E., Coumans, W. A., Bonen, A., Klip, A., Glatz, J. F., et al. (2010). Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes. Diabetologia 53, 2209-2219. doi:10.1007/s00125-010-1832-7.
73. Semenza, G. L. (2008). Tumor metabolism: cancer cells give and take lactate. J. Clin. Invest. 118, 3835-3837. doi:10.1172/JCI37373.
74. Shin, D. J., Joshi, P., Hong, S. H., Mosure, K., Shin, D. G., and Osborne, T. F. (2012). Genome-wide analysis of FoxO1 binding in hepatic chromatin: potential involvement of FoxO1 in linking retinoid signaling to hepatic gluconeogenesis. Nucleic Acids Res. 40, 11499-11509. doi:10.1093/nar/gks932.
75. Stokoe, D., Stephens, L. R., Copeland, T., Gaffney, P. R., Reese, C. B., Painter, G. F., et al. (1997). Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277, 567-570. doi:10.1126/science.277.5325.567.
76. Stronach, E. A., Chen, M., Maginn, E. N., Agarwal, R., Mills, G. B., Wasan, H., et al. (2011). DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance. Neoplasia 13, 1069-1080.
77. Tazzari, P. L., Cappellini, A., Grafone, T., Mantovani, I., Ricci, F., Billi, A. M., et al. (2004). Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry. Br. J. Haematol. 126, 675-681. doi:10.1111/j.1365-2141.2004.05121.x.
78. Thayyullathil, F., Chathoth, S., Shahin, A., Kizhakkayil, J., Hago, A., Patel, M., et al. (2011). Protein phosphatase 1-dependent dephosphorylation of Akt is the prime signaling event in sphingosine-induced apoptosis in Jurkat cells. J. Cell. Biochem. 112, 1138-1153. doi:10.1002/jcb.23033.
79. Thiem, S., Pierce, T. P., Palmieri, M., Putoczki, T. L., Buchert, M., Preaudet, A., et al. (2013). mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice. J. Clin. Invest. 123, 767-781. doi:10.1172/JCI65086.
80. Tsuchiya, K., Tanaka, J., Shuiqing, Y., Welch, C. L., DePinho, R. A., Tabas, I., et al. (2012). FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis. Cell Metab. 15, 372-381. doi:10.1016/j.cmet.2012.01.018.
81. Tsunekawa, S., Demozay, D., Briaud, I., McCuaig, J., Accili, D., Stein, R., et al. (2011). FoxO feedback control of basal IRS-2 expression in pancreatic beta-cells is distinct from that in hepatocytes. Diabetes 60, 2883-2891. doi:10.2337/db11-0340.
82. Vadlakonda, L., Pasupuleti, M., and Pallu, R. (2013). Role of PI3K-AKT-mTOR and Wnt signaling pathways in transition of G1-S phase of cell cycle in cancer cells. Front. Oncol. 3:85. doi:10.3389/fonc.2013.00085.
83. Vincent, E. E., Elder, D. J., Thomas, E. C., Phillips, L., Morgan, C., Pawade, J., et al. (2011). Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer. Br. J. Cancer 104, 1755-1761. doi:10.1038/bjc.
84. Weidberg, H., and Elazar, Z. (2011). TBK1 mediates crosstalk between the innate immune response and autophagy. Sci. Signal. 4, e39. doi:10.1126/scisignal.2002355.
85. White, M. F. (2003). Insulin signaling in health and disease. Science 302, 1710-1711. doi:10.1126/science.1092952.
86. Wu, N., Zheng, B., Shaywitz, A., Dagon, Y., Tower, C., Bellinger, G., et al. (2013). AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. Mol. Cell 49, 1167-1175. doi:10.1016/j.molcel.2013.01.035.
87. Xie, X., Zhang, D., Zhao, B., Lu, M. K., You, M., Condorelli, G., et al. (2011). IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 108, 6474-6479. doi:10.1073/pnas.1016132108.
88. Xu, W., Yuan, X., Jung, Y. J., Yang, Y., Basso, A., Rosen, N., et al. (2003). The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells. Cancer Res. 63, 7777-7784.
89. Yang, J., Cron, P., Thompson, V., Good, V. M., Hess, D., Hemmings, B. A., et al. (2002). Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol. Cell 9, 1227-1240. doi:10.1016/S1097-2765(02)00550-6.
90. Young, A. R., Narita, M., Ferreira, M., Kirschner, K., Sadaie, M., Darot, J. F., et al. (2009). Autophagy mediates the mitotic senescence transition. Genes Dev. 23, 798-803. doi:10.1101/gad.519709.
91. Zhang, H. H., Lipovsky, A. I., Dibble, C. C., Sahin, M., and Manning, B. D. (2006). S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt. Mol. Cell 24, 185-197. doi:10.1016/j.molcel.2006.09.019.
92. Zhu, Y., Pereira, R. O., O'Neill, B. T., Riehle, C., Ilkun, O., Wende, A. R., et al. (2013). Cardiac PI3K-Akt impairs insulin-stimulated glucose uptake independent of mTORC1 and GLUT4 translocation. Mol. Endocrinol. 27, 172-184. doi:10.1210/me.2012-1210.
93. Zong, H., Bastie, C. C., Xu, J., Fassler, R., Campbell, K. P., Kurland, I. J., et al. (2009). Insulin resistance in striated muscle-specific integrin receptor beta1-deficient mice. J. Biol. Chem. 284, 4679-4688. doi:10.1074/jbc.M807408200.